-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Graba
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on Synopsys (SNPS)
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grab
-
-
-
-
-
-
-
Synopsys Receives Final Regulatory Approval to Close Planned Divestitures of Synopsys Optical Solutions Group and Ansys PowerArtist
-
-
-
-
-
-
-
Synopsys Q3 preview: Analyst flags areas to watch for investors
-
-
-
-
-
-
-
Synopsys Completes Acquisition of Ansys
-
-
-
-
-
-
-
Goldman Sachs Starts Synopsys (SNPS) at Buy
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

